And now it gets more interesting. Major shareholder increases holding to over 20 percent. One director buys, another sells. Would appear no buy back yet. CFO gooooonne. Changes are afoot.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025